Internal Medicine · Huntersville, NC
NPI
1144602459
Since 2015
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
9920 Kincey Ave Ste 120
Huntersville, NC, 28078
Phone (704) 316-6360
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,718 services
Medicare patients, 2024
403
Average age 72
Drug cost, 2024
$1.6M
3,794 prescriptions
Company payments, 2025
$427
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shashpal Punshi was code 99214 (office e&m - established), 383 times for 236 patients. In total Shashpal Punshi billed 1,718 services in 21 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 383 | 236 | $83.67 | $32K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 322 | 239 | $11.75 | $3,784 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 225 | 46 | $47.44 | $11K |
| 95251 Test - Miscellaneous | Office | 169 | 101 | $23.63 | $3,994 |
| 99232 Hospital E&M - Subsequent | Facility | 166 | 47 | $58.88 | $9,774 |
| 99204 Office E&M - New | Office | 102 | 102 | $112.97 | $12K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 93 | 39 | $36.30 | $3,376 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 86 | 18 | $47.04 | $4,045 |
| 99222 Hospital E&M - Initial | Facility | 52 | 48 | $96.82 | $5,035 |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 27 | 14 | $35.87 | $968 |
| 99213 Office E&M - Established | Office | 14 | 12 | $62.84 | $880 |
| 99203 Office E&M - New | Office | 12 | 12 | $79.22 | $951 |
By year: 2022 $89K for 1,094 services; 2023 $150K for 2,384 services; 2024 $90K for 1,718 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shashpal Punshi prescribed most often to Medicare patients was Ozempic (Semaglutide), with 322 prescriptions and refills. In total Shashpal Punshi wrote 3,794 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 322 | 554 | 94 | $514K |
| Levothyroxine Sodium Generic | 306 | 873 | 127 | $3,121 |
| Atorvastatin Calcium Generic | 287 | 811 | 122 | $2,719 |
| Metformin Hcl Generic | 242 | 695 | 97 | $1,723 |
| Rosuvastatin Calcium Generic | 198 | 557 | 77 | $4,043 |
| Glipizide Generic | 131 | 356 | 56 | $1,014 |
| Jardiance Empagliflozin | 117 | 258 | 44 | $155K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 102 | 220 | 34 | $108K |
| Glimepiride Generic | 101 | 261 | 33 | $1,148 |
| Pioglitazone Hcl Generic | 89 | 249 | 37 | $1,123 |
| Ezetimibe Generic | 89 | 229 | 35 | $2,033 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 78 | 190 | 37 | $10K |
| Metformin Hcl Er Metformin Hcl | 74 | 220 | 34 | $702 |
| Ultra-Fine Micro Pen Needle Pen Needle, Diabetic | 71 | 197 | 36 | $11K |
| Gvoke Hypopen 2-Pack Glucagon | 67 | 68 | 50 | $42K |
Brand drugs: 1,725 claims; generic drugs: 1,841 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shashpal Punshi $427 ($427 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novo Nordisk Inc with $59.52.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 3 | $59.52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $59.18 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $56.34 |
| Xeris Pharmaceuticals, Inc. | 2 | $43.05 |
| Amgen Inc. AMGN | 2 | $42.84 |
| Soleno Therapeutics, Inc. SLNO | 2 | $40.47 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $27.1 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $24.04 |
| Dexcom, Inc. DXCM | 1 | $23.92 |
| Lilly USA, LLC LLY | 1 | $20.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.